EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

The Role of the TG2-GPR56 Complex in Cutaneous Squamous Cell Carcinoma (CSCC) Aggression and Therapeutic Resistance

David J Weber iD, Mary E Cook iD, Wenbo Yu iD, Maximino Redondo, Raquel Godoy-Ruiz iD

International Journal of Molecular Sciences · 23.03.2026 · 27 (6) · 2902

DOI: 10.3390/ijms27062902 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 23.03.2026. Verfasst von David J Weber und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biochemistry and Molecular Biology, University of Maryland School of Medicine, Baltimore, MD 21201, USA. Hauptthemen laut MEDLINE: Cutaneous Squamous Cell Carcinoma, Receptors, G-Protein-Coupled, Transglutaminases, Skin Neoplasms. Die Arbeit nennt 213 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Center for Biomolecular Therapeutics.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Cutaneous squamous cell carcinoma (cSCC) is the second most prevalent skin cancer diagnosed worldwide after basal cell carcinoma. CSCC represents a growing global public health challenge due to its higher potential of local invasion, recurrence, and metastasis. Incidence rates of cSCC are projected to increase due to rising exposures to risks factors. Ultraviolet light exposure is the primary cause, and lighter skin pigmentation, immunosuppressive conditions and skin phototype are the primary risk factors. CSCC typically presents as a red, scaly, flat lesion (in situ tumors) or a red, firm, raised lesion with scale or erosion (invasive tumors). Surgical excision remains the standard-of-care for localized cSCC and is often curative. Although, most patients achieve favorable outcomes, a subset of cSCC exhibits a highly aggressive and metastatic phenotype (postoperative recurrence rates are approximately 5%). Addressing the clinical challenge posed by these high-risk cases requires a more comprehensive understanding of the underlying molecular drivers. This review examines the interaction between transglutaminase 2 (TG2) and the G-protein-coupled receptor 56 (GPR56) as a pivotal driver of the aggressive cSCC phenotype. This molecular axis is particularly significant for its role in the maintenance of epidermal cancer stem (ECS) cells, which contribute to tumor progression and therapy resistance. While the definitive link between the TG2-GPR56 complex and systemic metastasis in cSCC is currently being elucidated, significant evidence from analogous malignancies and in vitro keratinocyte models provides a clear mechanistic roadmap for its involvement in tumor invasion.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cutaneous Squamous Cell CarcinomaReceptors, G-Protein-CoupledTransglutaminasesSkin NeoplasmsGTP-Binding ProteinsDrug Resistance, NeoplasmCarcinoma, Squamous CellHumansProtein Glutamine gamma Glutamyltransferase 2Animals

Stichwörter der Autor:innen

G-protein-coupled receptor GPR56TG2-GPR56 complexcutaneous squamous cell carcinoma (cSCC)epidermal cancer stem (ECS) cellstransglutaminase-2 (TG2)

Substanzen

Receptors, G-Protein-CoupledTransglutaminasesGTP-Binding ProteinsProtein Glutamine gamma Glutamyltransferase 2

Autor:innen und Institutionen

  • Department of Biochemistry and Molecular Biology, University of Maryland School of Medicine, Baltimore, MD 21201, USA.
  • Institute for Bioscience and Biotechnology Research (IBBR), University of Maryland, Rockville, MD 20850, USA.
  • The Center for Biomolecular Therapeutics (CBT), University of Maryland School of Medicine, Baltimore, MD 21201, USA.
  • Computer Aided Drug Design Center, Department of Pharmaceutical Sciences, School of Pharmacy, University of Maryland Baltimore, Baltimore, MD 21201, USA.
  • Department of Biochemistry, Molecular Biology and Immunology, School of Medicine, University of Malaga, 29010 Malaga, Spain.
  • Research Network on Chronicity, Primary Care and Prevention and Health Promotion (RICAPPS), Research and Innovation Unit, Costa del Sol University Hospital, 29603 Marbella, Spain.

ORCID-Profile: David J Weber, Mary E Cook, Wenbo Yu, Raquel Godoy-Ruiz

Förderung

  • Center for Biomolecular Therapeutics

Zitieren

APA

Weber, D. J., Cook, M. E., Yu, W., Redondo, M., & Godoy-Ruiz, R. (2026). The Role of the TG2-GPR56 Complex in Cutaneous Squamous Cell Carcinoma (CSCC) Aggression and Therapeutic Resistance. International Journal of Molecular Sciences, 27(6), 2902. https://doi.org/10.3390/ijms27062902

Vancouver

Weber DJ, Cook ME, Yu W, Redondo M, Godoy-Ruiz R. The Role of the TG2-GPR56 Complex in Cutaneous Squamous Cell Carcinoma (CSCC) Aggression and Therapeutic Resistance. International Journal of Molecular Sciences. 2026;27(6):2902. doi:10.3390/ijms27062902

BibTeX
@article{Weber2026,
  author = {Weber, David J and Cook, Mary E and Yu, Wenbo and Redondo, Maximino and Godoy-Ruiz, Raquel},
  title = {The Role of the TG2-GPR56 Complex in Cutaneous Squamous Cell Carcinoma (CSCC) Aggression and Therapeutic Resistance},
  journal = {International Journal of Molecular Sciences},
  year = {2026},
  volume = {27},
  number = {6},
  pages = {2902},
  doi = {10.3390/ijms27062902}
}
Kostenlos starten →